Mark A Goldsmith's Stock Transactions in Revolution Medicines Inc

Mark A Goldsmith, a director and officer of Revolution Medicines Inc, has filed a Form 144 detailing his stock transactions. On 10/17/2025, Goldsmith exercised stock options to acquire 10,000 shares of common stock. Additionally, he sold 10,000 shares on 10/16/2025 for a total value of $504,701.00 and 13,411 shares on 09/16/2025 for $614,557.73. The transactions were executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing indicates that these transactions are part of a pre-arranged trading plan adopted on 12/19/2024.